Learn how GenAI is transforming early drug discovery by designing novel, drug-like small molecules with improved potency, selectivity, and ADME properties.
Explore how GenAI integrates with synthesis planning and automation tools to prioritize viable candidates and accelerate iterative drug development.
Speaker(s):
Yue-Wang Webster
Vice President, Model Driven Drug Discovery Platforms
Eli Lilly
Time:
11:45 AM - 12:15 PM
Agenda Track No.:
Track 2
Session Type:
General Session (Presentation)